Guobo Shen

6.1k total citations · 3 hit papers
74 papers, 3.2k citations indexed

About

Guobo Shen is a scholar working on Molecular Biology, Immunology and Oncology. According to data from OpenAlex, Guobo Shen has authored 74 papers receiving a total of 3.2k indexed citations (citations by other indexed papers that have themselves been cited), including 40 papers in Molecular Biology, 24 papers in Immunology and 14 papers in Oncology. Recurrent topics in Guobo Shen's work include Immunotherapy and Immune Responses (10 papers), Immune cells in cancer (8 papers) and RNA Interference and Gene Delivery (7 papers). Guobo Shen is often cited by papers focused on Immunotherapy and Immune Responses (10 papers), Immune cells in cancer (8 papers) and RNA Interference and Gene Delivery (7 papers). Guobo Shen collaborates with scholars based in China, United States and Japan. Guobo Shen's co-authors include Na Xie, Canhua Huang, Zhao Huang, Li Fu, Wei Gao, Yuquan Wei, Wei Gao, Xiaobo Zhou, Lu Zhang and Changlong Li and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Journal of Clinical Investigation.

In The Last Decade

Guobo Shen

72 papers receiving 3.1k citations

Hit Papers

NAD+ metabolism: pathophysiologic mechanisms and therapeu... 2020 2026 2022 2024 2020 2023 2024 200 400 600
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. NAD+ metabolism: pathophysiologic mechanisms and therapeutic potential
    2020 608 citations Na Xie, Guobo Shen et al. Signal Transduction and Targeted Therapy profile →
  2. Neoantigens: promising targets for cancer therapy
    2023 536 citations Na Xie, Guobo Shen et al. Signal Transduction and Targeted Therapy profile →
  3. Nanotechnology’s frontier in combatting infectious and inflammatory diseases: prevention and treatment
    2024 231 citations Yi Wu, Na Xie et al. Signal Transduction and Targeted Therapy profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Guobo Shen China 27 1.6k 778 681 389 295 74 3.2k
Maria Teresa Scupoli Italy 31 1.2k 0.8× 770 1.0× 692 1.0× 421 1.1× 156 0.5× 75 3.0k
Jelena Vider United States 25 1.2k 0.7× 970 1.2× 930 1.4× 495 1.3× 457 1.5× 51 3.2k
Andrea Petretto Italy 34 1.5k 0.9× 1.1k 1.4× 675 1.0× 351 0.9× 359 1.2× 136 3.6k
Song Zhang China 35 1.3k 0.8× 988 1.3× 409 0.6× 295 0.8× 225 0.8× 89 3.0k
Liang Liang China 30 1.5k 0.9× 572 0.7× 462 0.7× 686 1.8× 205 0.7× 100 2.8k
Ye Chen China 32 2.3k 1.5× 1.2k 1.5× 963 1.4× 691 1.8× 253 0.9× 136 4.6k
Xueqing Zhang China 29 1.7k 1.0× 1.1k 1.4× 569 0.8× 839 2.2× 307 1.0× 67 3.4k
Tao Yi China 36 1.9k 1.2× 868 1.1× 673 1.0× 831 2.1× 181 0.6× 206 4.1k
Beate Rinner Austria 26 1.3k 0.8× 417 0.5× 413 0.6× 368 0.9× 243 0.8× 102 2.6k
Margit Rosner Austria 28 2.3k 1.4× 690 0.9× 710 1.0× 377 1.0× 329 1.1× 96 4.0k

Countries citing papers authored by Guobo Shen

Since Specialization
Citations

This map shows the geographic impact of Guobo Shen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Guobo Shen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Guobo Shen more than expected).

Fields of papers citing papers by Guobo Shen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Guobo Shen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Guobo Shen. The network helps show where Guobo Shen may publish in the future.

Co-authorship network of co-authors of Guobo Shen

This figure shows the co-authorship network connecting the top 25 collaborators of Guobo Shen. A scholar is included among the top collaborators of Guobo Shen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Guobo Shen. Guobo Shen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Shen, Guobo, et al.. (2025). Therapeutic potential of tumor-associated neutrophils: dual role and phenotypic plasticity. Signal Transduction and Targeted Therapy. 10(1). 178–178. 16 indexed citations
2.
Chang, Qing, Yaying Zhang, Xiaojun Liu, et al.. (2025). Oxidative Stress in Antigen Processing and Presentation. SHILAP Revista de lepidopterología. 4(2). 5 indexed citations
3.
Gao, Yan, Kaiyu Wang, Yi Wu, et al.. (2025). Controlled release of MIF siRNA and GDNF protein from a photocurable scaffold efficiently repairs spinal cord injury. MedComm. 6(3). e70099–e70099.
4.
Shen, Guobo, et al.. (2025). The Effect and Mechanism of Iodine Curing on SiC Green Fibers Derived from Polymethylsilane (PMS) via Melt Spinning. Journal of Inorganic and Organometallic Polymers and Materials. 35(7). 6067–6079. 1 indexed citations
5.
Zheng, Lei, Xiaodong Wang, Ping Xu, et al.. (2025). Developing lightweight C/(Zr, Hf)C-SiC composite with broadband EMI shielding performance and structural stability using recycled carbon fibers. Ceramics International. 51(20). 31456–31465. 2 indexed citations
6.
7.
Yu, Jiayun, et al.. (2024). Inhibition of NLRP3 inflammasome activation by A20 through modulation of NEK7. Proceedings of the National Academy of Sciences. 121(25). e2316551121–e2316551121. 14 indexed citations
8.
Shen, Guobo, et al.. (2024). The potential and promise for clinical application of adoptive T cell therapy in cancer. Journal of Translational Medicine. 22(1). 413–413. 14 indexed citations
9.
Wu, Yi, et al.. (2024). The biological essence of synthetic lethality: Bringing new opportunities for cancer therapy. SHILAP Revista de lepidopterología. 3(1). 9 indexed citations
10.
Shen, Guobo, et al.. (2024). mRNA therapies: Pioneering a new era in rare genetic disease treatment. Journal of Controlled Release. 369. 696–721. 23 indexed citations
11.
He, Cai, Aqu Alu, Lei Hong, et al.. (2023). A recombinant spike‐XBB.1.5 protein vaccine induces broad‐spectrum immune responses against XBB.1.5‐included Omicron variants of SARS‐CoV‐2. SHILAP Revista de lepidopterología. 4(3). e263–e263. 11 indexed citations
12.
Yang, H. J., Weiqi Hong, Lei Hong, et al.. (2023). Low levels of neutralizing antibodies against XBB Omicron subvariants after BA.5 infection. Signal Transduction and Targeted Therapy. 8(1). 252–252. 20 indexed citations
13.
Guo, Xiaohan, Yi Wu, Xue Ying, Na Xie, & Guobo Shen. (2023). Revolutionizing cancer immunotherapy: unleashing the potential of bispecific antibodies for targeted treatment. Frontiers in Immunology. 14. 1291836–1291836. 15 indexed citations
14.
Luo, Min, Zhipeng Meng, Toshiro Moroishi, et al.. (2020). Publisher Correction: Heat stress activates YAP/TAZ to induce the heat shock transcriptome. Nature Cell Biology. 23(2). 209–209. 2 indexed citations
15.
Luo, Min, Zhipeng Meng, Toshiro Moroishi, et al.. (2020). Heat stress activates YAP/TAZ to induce the heat shock transcriptome. Nature Cell Biology. 22(12). 1447–1459. 69 indexed citations
16.
Taylor, Sarah E., Caitlin M. O’Connor, Zhizhi Wang, et al.. (2019). The Highly Recurrent PP2A Aα-Subunit Mutation P179R Alters Protein Structure and Impairs PP2A Enzyme Function to Promote Endometrial Tumorigenesis. Cancer Research. 79(16). 4242–4257. 42 indexed citations
17.
Yang, Yanfang, Ziwei Liang, Zijing Xia, et al.. (2019). SAE1 promotes human glioma progression through activating AKT SUMOylation-mediated signaling pathways. Cell Communication and Signaling. 17(1). 82–82. 43 indexed citations
18.
19.
Nie, Wen, Xuelei Ma, Yaxiong Sang, et al.. (2012). Synergic antitumor effect of SKLB1002 and local hyperthermia in 4T1 and CT26. Clinical and Experimental Medicine. 14(2). 203–213. 7 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Maria Teresa Scupoli Breakdown of academic impact, for papers by Jelena Vider Breakdown of academic impact, for papers by Andrea Petretto Breakdown of academic impact, for papers by Song Zhang Breakdown of academic impact, for papers by Liang Liang Breakdown of academic impact, for papers by Ye Chen Breakdown of academic impact, for papers by Xueqing Zhang Breakdown of academic impact, for papers by Tao Yi Breakdown of academic impact, for papers by Beate Rinner Breakdown of academic impact, for papers by Margit Rosner
Rankless by CCL
2026